ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Tolerance"

  • 2016 American Transplant Congress

    Tofacitinib Delivered by Solid Lipid Nanoparticles Inhibits Dendritic Cell Maturation and Their Allostimulatory Capacity.

    J. Budihardjo,1 M. Iglesias,1 J. Walch,1 X. Calderon-Colon,2 W. Lee,1 G. Brandacher,1 J. Patrone,2 G. Raimondi.1

    1Plastic Surgery, Johns Hopkins Medical Institutions, Baltimore, MD; 2Applied Physics Laboratory, Johns Hopkins University, Laurel, MD.

    BackgroundComplications caused by long-term immunosuppression remain a major concern for transplant patients. To optimize controlled and accurate dosing, we investigated an innovative drug delivery method…
  • 2016 American Transplant Congress

    HLA Identical or Haploidentical Combined Kidney and Bone Marrow Transplantation for Multiple Myeloma with End-Stage Renal Failure.

    T. Kawai,1 Y.-B. Chen,1 M. Sykes,2 C. Benedict,1 N. Tolkoff-Rubin,1 B. Day,1 S. McAfee,1 K. Ballen, S. David,1 T. Spitzer.1

    1Massachusetts General Hospital, Boston; 2Columbia University, New York.

    Patients with multiple myeloma (MM) who developed end-stage renal disease (ESRD) are generally not eligible for either kidney transplantation or allogeneic stem-cell transplant. We performed…
  • 2016 American Transplant Congress

    TGFb in Regulatory B Cells-Dependent Tolerance.

    H. Deirawan, L. Kojima, L. Washburn, J. Markmann, J. Kim.

    Surgery, Massachusetts General Hospital, Boston, MA.

    In transplantation, increasing evidence support that B cells can play a major regulatory role in addition to their critical functions in allo-immunity and graft rejection.…
  • 2016 American Transplant Congress

    A Single Histone/protein Acetyltransferase, Tip60, Is Absolutely Essential for Treg Survival and Function, and Its Inhibition Abrogates Induction of Treg-Dependent Allograft Tolerance.

    L. Wang,1 A. Beeler,2 S. Dahiya,1 R. Han,1 W. Hancock.1

    1CHOP & UPenn, Philadelphia, PA; 2Boston University, Boston, MA.

    Based on in vitro studies and limited in vivo data from patients with mutations in FOXP3 or animals with depletion of circulating Tregs, Tregs are…
  • 2016 American Transplant Congress

    MicroRNA let-7i Regulates Dendritic Cells Maturation Targeting Interleukin-10 via JAK1-STAT3 Signal Pathway Subsequently Induces Prolonged Cardiac Allograft Survival in Rats.

    X. Jin,1 Y. Sun,2 X. Liu,2 J. Wang,1 S. Xu,1 L. Yao,1 Z. Zhao,3 L. Jiang,4 Q. Wu,5 J. Wu.2

    1Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China; 2Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; 3Pediatric Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China; 4Otorhinolaryngology, The First Affiliated Hospital of Harbin Medical University, Harbin, China; 5Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

    Background:Our previous study demonstrated that microRNA (MiR) let-7i could regulate dendritic cells (DCs) maturation and functional state via targeting SOCS1. In this study, we investigated…
  • 2016 American Transplant Congress

    Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.

    L. Gallon,1 J. Leventhal,1 C. Dumur,2 J. Mathew,1 L. Nadimpalli,1 A. Shetty,1 S. Ildstad,3 V. Mas.2

    1Medicine/Nephrology, Northwestern University, Chicago, IL; 2Medicine/Nephology, University of Virginia Health System, Charlottesville, VA; 3Immunology, University of Louisville, Louisville, KT.

    Organ transplantation relies upon nonspecific immunosuppressive (IS) agents to prevent graft rejection. However, IS drugs have significant toxicities and chronic rejection occurs despite their usage.…
  • 2016 American Transplant Congress

    Tolerance Induction with Donor Bone Marrow Transplantation in Kidney Transplantation.

    H. Park,1 N. Lee,1 S. Lee,1 G. Choi,1 C. Kwon,1 S. Kim,1 J.-W. Joh,1 M. Kim,2 Y. Kwon,2 S.-K. Lee.1

    1Department of Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea; 2Transplantation Research Center, Samsung Biomedical Research Institute, Seoul, Republic of Korea.

    Tolerance induction is considered to be a final goal in the field of organ transplantation. We have performed simultaneous bone marrow and kidney transplantation in…
  • 2016 American Transplant Congress

    Fate of Endogenous Alloreactive B Cells in Transplant Tolerance.

    J. Chen,1 J. Yang,1 A. Akl,1 Q. Wang,1 D. Yin,1 R. Sciammas,2 A. Chong.1

    1Transplant Surgery, University of Chicago, Chicago, IL; 2Methodist Research Institute, Methodist Medical Center, Houston, TX.

    The conceptual underpinning of our studies is that robust tolerance requires multiple mechanisms to enforce functional quiescence of alloreactive T and B cells. While much…
  • 2016 American Transplant Congress

    HLA Identical Renal Transplant Tolerance Using Donor Hematopoietic Stems Cells (DHSC): Role of Immunoregulation.

    J. Leventhal,1 J. Mathew,1 D. Salomon,2 S. Kurian,2 J. Friedewald,1 L. Gallon,1 X. Huang,1 A. Tambur,1 Y. Kanwar,1 J. Charette,1 M. Abecassis,1 J. Miller.1

    1Surgery - Comprehensive Transplant Center, Northwestern University, Chicago, IL; 2The Scripps Research Institute, La Jolla, CA.

    Purpose: Despite being a “perfect match”, HLA-identical kidney transplants (HLA-Id KTx) are rejected without sufficient immunosuppression (IS), and hence can also benefit from tolerance induction.…
  • 2016 American Transplant Congress

    Neonatal Tolerance to Blood Group A-Antigen in a Mouse Model of ABO-Incompatible Heart Transplantation (ABOi HTx).

    B. Motyka,1 B. Lamarche,1 K. Labonte,1 S. Wang,1 J. Pearcey,1 K. Tao,1 M. Mengel,1 B. Sis,1 P. Cowan,2 L. West.1

    1Alberta Transplant Institute/CNTRP, University of Alberta, Edmonton, Canada; 2Immunology Research Centre, St Vincent's Hospital, Melbourne, Australia.

    Purpose: ABOi HTx can be performed safely in infants due to lack of natural anti-A/B antibodies (Ab), in contrast to adults. Following ABOi HTx, B…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 57
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences